A RANDOMIZED CONTROLLED TRIAL TO COMPARE THE EFFICACY OF TACROLIMUS WITH MYCOPHENOLATE MOFETIL IN PATIENTS WITH SYSTEMIC SCLEROSIS - INTERSTITIAL LUNG DISEASE (INSIST TRIAL)

被引：0
|
作者：
Mathew, J. [1 ]
Kopp, C. [1 ]
Sharma, S. K. [1 ]
Dhir, V. [1 ]
Dhooria, S. [2 ]
Sinha, A. [3 ]
Jain, S. [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Internal Med, Chandigarh, India
[2] Post Grad Inst Med Educ & Res, Pulm Med, Chandigarh, India
[3] Post Grad Inst Med Educ & Res, Radiodiag, Chandigarh, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Clinical Trials; Systemic sclerosis; Lungs;
D O I：
10.1136/annrheumdis-2023-eular.3107
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0240
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [31] Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease
    Konstantinos Gkiouras
    Maria G. Grammatikopoulou
    Theodora Simopoulou
    Zoe Daniil
    Dimitrios P. Bogdanos
    Clinical Rheumatology, 2021, 40 : 3379 - 3380
  • [32] A randomized, prospective, comparative trial of tacrolimus-mycophenolate mofetil and neoral-mycophenolate mofetil in kidney transplantation.
    Ahsan, N
    Holman, MJ
    Ulsh, PJ
    Langhoff, EG
    Yang, HC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3130 - A3130
  • [33] Randomized controlled trial to compare the efficacy and safety of mycophenolate mofetil versus levamisole in children with frequently relapsing and steroid dependent nephrotic syndrome
    Sinha, A.
    Puraswani, M.
    Rawat, M.
    Hari, P.
    Bagga, A.
    PEDIATRIC NEPHROLOGY, 2014, 29 (12) : 2434 - 2434
  • [34] COMPARISON OF LONG-TERM CYCLOPHOSPHAMIDE (CY) AND MYCOPHENOLATE MOFETIL (MMF) EFFICACY AND SAFETY IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) AND INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ovsyannikova, O.
    Desiniva, O.
    Garzanova, L.
    Ananieva, L.
    Starovoytova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1108 - 1109
  • [35] Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Xinyu Ma
    Rui Tang
    Mei Luo
    Zhuotong Zeng
    Yaqian Shi
    Bingsi Tang
    Rong Xiao
    Clinical Rheumatology, 2021, 40 : 3185 - 3193
  • [36] Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Ma, Xinyu
    Tang, Rui
    Luo, Mei
    Zeng, Zhuotong
    Shi, Yaqian
    Tang, Bingsi
    Xiao, Rong
    CLINICAL RHEUMATOLOGY, 2021, 40 (08) : 3185 - 3193
  • [37] A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62557616]
    Hogg R.J.
    Wyatt R.J.
    BMC Nephrology, 5 (1) : 1 - 9
  • [38] Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial
    Volkmann, Elizabeth H.
    McMahan, Zsuzsanna
    Smith, Vanessa
    Jouneau, Stephane
    Miede, Corinna
    Alves, Margarida L.
    Herrick, Ariane
    ARTHRITIS CARE & RESEARCH, 2023, 75 (12) : 2501 - 2507
  • [39] COMPARISON OF THE RITUXIMAB(RTM) IN MONOTHERAPY REGIMEN AND MYCOPHENOLATE MOFETIL (MMF) EFFICACY AND SAFETY IN SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 704 - 704
  • [40] A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone mycophenolate mofetil in renal transplant recipients
    Shapiro, R
    Jordan, ML
    Scantlebury, VP
    Vivas, C
    Marsh, JM
    McCauley, J
    Johnston, J
    Randhawa, P
    Irish, W
    Gritsch, HA
    Naraghi, R
    Hakala, TR
    Fung, JJ
    Starzl, TE
    TRANSPLANTATION, 1999, 67 (03) : 411 - 415
12345